FDA scientists opposed the Trump administration's plan to ease access to unproven peptide drugs, citing safety concerns and limited scientific input in the policy's development.
AI-generated summary. Check the original reporting for context and accuracy.
This is the available feed excerpt, which may be shortened or in the publisher’s original language.
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientistsA plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development.The document posted online on Wednesday by Kennedy’s Department of Health and Human Services (HHS) covers a handful of injectable peptides promoted within the wellness industry for building muscle, healing injuries and boosting energy. Continue reading...
An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.
Chalmers' condemnation of social media as a hate engine and the alarming perception of the US as a threat among young Australians highlight deepening societal and geopolitical divisions.
Spain's deadliest train crash in years killed at least 68 people, marking a second major disaster on the same rail line within a year.
Trump is demanding the disqualification of Alaska Senate candidate Mary Peltola, alleging her campaign illegally recruited a man with the same name as her opponent to confuse voters.